Trials / Withdrawn
WithdrawnNCT04793373
Superiority of Epidural Placement Technique Using EpiFaith Syringe
Superiority of Epidural Placement Technique Using EpiFaith® Syringe Versus Conventional Glass Syringe in Laboring Paturients
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Harvard Medical School (HMS and HSDM) · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the impact of EpiFaith® syringe on the establishment of successful epidural labor analgesia, change of elapsed time for identification of epidural space, and learning curve of CA-1 residents.
Detailed description
We hypothesize that EpiFaith® syringe, in comparison with conventional glass syringe, will result in a similar overall success rate for catheter placement, but with a larger reduction in change of elapsed time for identification of epidural space and catheter placement of each practitioner. Moreover, we hypothesize that the cumulative learning summary curve using EpiFaith® syringe will be higher than conventional glass syringe in resident trainees, which will show the possible value of EpiFaith® syringe for teaching and learning obstetric epidural anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Syringe | A syringe will be used to detect the loss of resistance and needle's entry of epidural space. |
Timeline
- Start date
- 2022-05-15
- Primary completion
- 2025-12-31
- Completion
- 2026-06-30
- First posted
- 2021-03-11
- Last updated
- 2023-07-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04793373. Inclusion in this directory is not an endorsement.